The Patent Finder
SS

Stimvia S.R.O.

First filing 2018
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Previously recorded as Tesla Medical S.R.O. (to 2023)

11 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Oct 2036. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Oct 2036
Next term end
5
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 17, 2027
    The maintenance fee for Selective Neuromodulation Apparatus (US 11,786,722) comes due Apr 17, 2027. Unpaid by Oct 18, 2027, it lapses early.
  • 1 fee due Jun 12, 2027
    The maintenance fee for Neuromodulation Medical Treatment Device (US 11,839,762) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
  • 1 fee due Aug 13, 2027
    The maintenance fee for Method for Neuromodulation Treatment of Low Urinary Tract Dysfunction (US 11,896,824) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 11,446,490Method for a Neuromodulation Treatment
In force
 · High confidence
In forceHigh confidence
US 11,638,814Method for Neuromodulation Treatment of Neurodegenerative Disease
In force
 · High confidence
In forceHigh confidence
US 11,839,762Neuromodulation Medical Treatment Device
In force
 · High confidence
In forceHigh confidence
US 11,896,824Method for Neuromodulation Treatment of Low Urinary Tract Dysfunction
In force
 · Medium confidence
In forceMedium confidence
US 12,714,853Method and Device for Activation of Brain Regions
In force
 · Low confidence
In forceLow confidence
US 10,874,869Electrostimulation Device
In force
 · High confidence
In forceHigh confidence
US 11,420,052A Device and Method for Neuromodulation Treatment
In force
 · High confidence
In forceHigh confidence
US 11,400,277Neuromodulation Electrode Assembly
In force
 · High confidence
In forceHigh confidence
US 11,786,722Selective Neuromodulation Apparatus
In force
 · High confidence
In forceHigh confidence
US 12,226,624Selective Neuromodulation Apparatus
In force
 · Medium confidence
In forceMedium confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
Also on record, not counted in the 11: 2 applications pending. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited